The paradigm of protein acetylation in Parkinson’s disease
Main Authors: | Sokhna M.S. Yakhine-Diop, Guadalupe Martínez-Chacón, Elisabet Uribe-Carretero, Mireia Niso-Santano, Rosa A González-Polo, José M Fuentes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2019;volume=14;issue=6;spage=975;epage=976;aulast=Yakhine-Diop |
Similar Items
-
Toxicity of Necrostatin-1 in Parkinson’s Disease Models
by: Eva Alegre-Cortés, et al.
Published: (2020-06-01) -
Acetylome in Human Fibroblasts From Parkinson's Disease Patients
by: Sokhna M. S. Yakhine-Diop, et al.
Published: (2018-04-01) -
Loss of KEAP1 Causes an Accumulation of Nondegradative Organelles
by: Elisabet Uribe-Carretero, et al.
Published: (2022-07-01) -
In vitro and in vivo models to study the biological and pharmacological properties of queen bee acid (QBA, 10-hydroxy-2-decenoic acid): A systematic review
by: Marta Paredes-Barquero, et al.
Published: (2022-07-01) -
Biological effects of olive oil phenolic compounds on mitochondria
by: Mercedes Blanco-Benítez, et al.
Published: (2022-12-01)